DATA-DERIVED SAFETY FACTORS FOR THE EVALUATION OF FOOD-ADDITIVES AND ENVIRONMENTAL CONTAMINANTS

被引：247

作者：

RENWICK, AG

机构：

[1] Clinical Pharmacology Group, University of Southampton, Southampton, SO9 3TU, Bassett Crescent East

来源：

FOOD ADDITIVES AND CONTAMINANTS | 1993年 / 10卷 / 03期

关键词：

ACCEPTABLE DAILY INTAKE; ADI; SAFETY FACTOR; TOXICOKINETICS; TOXICODYNAMICS; NOAEL;

D O I：

10.1080/02652039309374152

中图分类号：

O69 [应用化学];

学科分类号：

081704 ;

摘要：

A safety factor of 100-fold is commonly applied to animal data to derive the acceptable daily intake (ADI) of food additives; other factors have been used in some cases and higher values are used more frequently for determining the tolerable daily intake (TDI) of environmental chemicals. The 100-fold factor is considered to represent the product of a 10-fold factor to allow for species differences between the test animal and humans and a 10-fold factor to allow for inter-individual differences. A scheme is proposed whereby data relevant to the safety assessment of a compound, e.g. species differences in toxicokinetics, can contribute quantitatively to the safety factor and therefore to the ADI or TDI. For this to be possible, it is necessary to subdivide each of the 10-fold factors into two separate factors to allow for differences in toxicokinetics and toxicodynamics. For any compound, data on one particular aspect may be used to derive a specific data-derived factor for that aspect. The overall safety factor will then be calculated as the product of the known data-derived factor(s) and default values for the remaining unknown factors. In this way the derivation of the safety factor would be clearly defined and the potential impact of additional data on other aspects identified. Additional safety factors (over and above the 100-fold or overall data-derived factor) are also proposed to allow for the nature or severity of the toxicity and the adequacy of the database. These factors are consistent with previous evaluations and will allow the logical derivation of factors greater than either 100 or the appropriate data-derived factor. These additional factors will be of greatest value in the derivation of safety factors for the calculation of the TDIs of environmental contaminants but may also be applied if necessary to the safety assessment of food additives. In such cases the rationale and logic for a safety factor in excess of 100 will be clearly defined.

引用

页码：275 / 305

页数：31

共 59 条

[1] Abernethy D.R., Gutkowska J., Winterbottom L.J., Effects of amlodipine, a long acting dihydropyridine calcium antagonist in ageing hypertension: Pharmacodynamics in relation to disposition, Clinical Pharmacology and Therapeutics, 48, pp. 76-86, (1990)
[2] Bachmann K., Predicting toxicokinetic parameters in humans from toxicokinetic data acquired from three small mammalian species, Journal of Applied Toxicology, 9, pp. 331-338, (1989)
[3] Bernard A.M., Lauwerys R.R., Noel A., Vandeleene B., Lambert A., Urine protein 1: A sex-dependent marker of tubular or glomerular dysfunction, Clinical Chemistry, 2141-2142, (1989)
[4] Bichet N., Cahard D., Fabre G., Remandet B., Gouy D., Cano J.-P., Toxicological studies on a benzofuran derivative. III Comparison of peroxisome proliferation in rat and human hepatocytes in primary culture, Toxicology and Applied Pharmacology, 106, pp. 509-517, (1990)
[5] Birge R.B., Bartolone J.B., Emeigh Hart S.G., Nishanian E.V., Tyson C.A., Khairallah E.A., Cohen S.D., Acetaminophen hepatotoxicity: Correspondence of selective protein arylation in human and mouse liver in vitro, in culture and, In Vivo. Toxicology and Applied Pharmacology, 105, pp. 472-482, (1990)
[6] Blychert E., Edgar B., Elmfeldt D., Hednor T., A population study of the pharmacokinetics of felodipine, British Journal of Clinical Pharmacology, 31, pp. 15-24, (1991)
[7] Borghoff S.J., Miller A.B., Bowen J.P., Swenberg J.A., Characteristics of chemical binding to α2u-globulin in vitro—evaluating structure-activity relationships, Toxicology and Applied Pharmacology, 107, pp. 228-238, (1991)
[8] Calabrese E.J., Uncertainty factors and interindividual variation, Regulatory Toxicology and Pharmacology, 5, pp. 190-196, (1985)
[9] Calabrese E.J., Moore G.S., Mc Carthy M.S., The effect of ascorbic acid on copperinduced oxidative changes in the erythrocytes of rats, sheep and normal humans, Regulatory Toxicology and Pharmacology, 3, pp. 179-183, (1983)
[10] Calabrese E.J., Moore G.S., Mc Carthy M.S., The effect of ascorbic acid on nitriteinduced methemoglobin formation in sheep, rats and normal human erythrocytes, Regulatory Toxicology and Pharmacology, 3, pp. 184-188, (1983)

← 1 2 3 4 5 6 →